Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $976,483 | $503,999 | – | $538,930 |
| - Cash | $128,640 | $155,900 | – | $94,900 |
| + Debt | $397,100 | $404,100 | – | $449,700 |
| Enterprise Value | $1,244,943 | $752,199 | – | $893,730 |
| Revenue | $432,832 | – | $463,000 | $324,600 |
| % Growth | – | – | 42.6% | – |
| Gross Profit | $236,176 | – | $304,000 | $207,700 |
| % Margin | 54.6% | – | 65.7% | 64% |
| EBITDA | $50,676 | – | $115,000 | -$4,500 |
| % Margin | 11.7% | – | 24.8% | -1.4% |
| Net Income | -$13,442 | – | $25,300 | -$20,800 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 253.6% | – |
| Operating Cash Flow | -$21,642 | – | $184,039 | $35,300 |
| Capital Expenditures | -$5,646 | – | -$5,424 | -$4,200 |
| Free Cash Flow | -$27,287 | – | $178,614 | $31,100 |